ADVANCE POC I Risk pillar - Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: Incidence rates of safety outcomes of whole-cell pertussis and acellular pertussis vaccines in pre-school children

First published 14/06/2016

Last updated 02/07/2024

EU PAS number:

EUPAS13779

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

ADVANCE POC-Risk-Protocol

English (1.84 MB - PDF) View document

Study results

ADVANCE D5 6_ExecSummaryEU-PAS

English (221.73 KB - PDF) View document

Study report

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

Signed checklist for study protocols

ENCePPChecklistforStudyProtocols ADVANCE POC risk

English (117.04 KB - PDF) View document

ADVANCE POC I Risk pillar - Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: Incidence rates of safety outcomes of whole-cell pertussis and acellular pertussis vaccines in pre-school children

Secondary tabs

Share this page